GALR2 peptide

  • Check with publisher
  • Published date: June 25, 2019
    • Shirley, New York, United States

Galanin is an important neuromodulator present in the brain, gastrointestinal system, and hypothalamopituitary axis. It is a 30-amino acid non-C-terminally amidated peptide that potently stimulates growth hormone secretion, inhibits cardiac vagal slowing of heart rate, abolishes sinus arrhythmia, and inhibits postprandial gastrointestinal motility. The actions of galanin are mediated through interaction with specific membrane receptors that are members of the 7-transmembrane family of G protein-coupled receptors. GALR2 interacts with the N-terminal residues of the galanin peptide. The primary signaling mechanism for GALR2 is through the phospholipase C/protein kinase C pathway (via Gq), in contrast to GALR1, which communicates its intracellular signal by inhibition of adenylyl cyclase through Gi. However, it has been demonstrated that GALR2 couples efficiently to both the Gq and Gi proteins to simultaneously activate 2 independent signal transduction pathways. [provided by RefSeq, Jul 2008] https://www.creative-diagnostics.com/GALR2-peptide-180368-436.htm

Thomas Schmitt
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Recombinant HAV Protein (aa 5-164)

    Recombinant HAV Protein (aa 5-164)

    Clinical/Medical Sciences Shirley (New York) August 29, 2019 Check with publisher

    The Hepatitis A virus (HAV), or Hepatovirus A, is a virus of the Picornaviridae family. It takes human and vertebrates as its natural hosts. HAV isolates all belong to a single serotype, seven genetic groups now have been defined, four for humans (ge...

  • Conducting a Behavioral Health Risk Assessment

    Conducting a Behavioral Health Risk Assessment

    Clinical/Medical Sciences Fremont (California) August 26, 2019 Check with publisher

    Overview: There are some unique challenges to identifying the most significant compliance risks in the delivery of behavioral health services. This presentation will address both the risk assessment process and the specific risk areas associated with...

  • Developing a Compliance Program for Small and Rural Health Care Providers

    Developing a Compliance Program for Small and Rural Health Care Providers

    Clinical/Medical Sciences Fremont (California) August 26, 2019 Check with publisher

    Overview: This presentation will cover the reasons for the need for a compliance program, the elements of a compliance program that will pass muster with state or federal investigators, the purpose of each of those elements, suggestions for implement...